世界の生体吸収性医療用ポリマー&材料市場インサイト及び予測(PLA、PGA、PCL、多糖類、その他)

◆英語タイトル:Global Bioresorbable Medical Polymer and Material Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX00515)◆商品コード:QY22JLX00515
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:93
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,489,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、生体吸収性医療用ポリマー&材料のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に生体吸収性医療用ポリマー&材料の世界市場のxxx%を占める「PLA」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「医療機器」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
生体吸収性医療用ポリマー&材料の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの生体吸収性医療用ポリマー&材料市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

生体吸収性医療用ポリマー&材料のグローバル主要企業には、Evonik、Corbion、DSM、Mitsui Chemicals、PCAS、Poly-Med、KLS Martinなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

生体吸収性医療用ポリマー&材料市場は、種類と用途によって区分されます。世界の生体吸収性医療用ポリマー&材料市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
PLA、PGA、PCL、多糖類、その他

【用途別セグメント】
医療機器、ドラッグデリバリー、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 生体吸収性医療用ポリマー&材料製品概要
- 種類別市場(PLA、PGA、PCL、多糖類、その他)
- 用途別市場(医療機器、ドラッグデリバリー、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の生体吸収性医療用ポリマー&材料販売量予測2017-2028
- 世界の生体吸収性医療用ポリマー&材料売上予測2017-2028
- 生体吸収性医療用ポリマー&材料の地域別販売量
- 生体吸収性医療用ポリマー&材料の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別生体吸収性医療用ポリマー&材料販売量
- 主要メーカー別生体吸収性医療用ポリマー&材料売上
- 主要メーカー別生体吸収性医療用ポリマー&材料価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(PLA、PGA、PCL、多糖類、その他)
- 生体吸収性医療用ポリマー&材料の種類別販売量
- 生体吸収性医療用ポリマー&材料の種類別売上
- 生体吸収性医療用ポリマー&材料の種類別価格
・用途別市場規模(医療機器、ドラッグデリバリー、その他)
- 生体吸収性医療用ポリマー&材料の用途別販売量
- 生体吸収性医療用ポリマー&材料の用途別売上
- 生体吸収性医療用ポリマー&材料の用途別価格
・北米市場
- 北米の生体吸収性医療用ポリマー&材料市場規模(種類別、用途別)
- 主要国別の生体吸収性医療用ポリマー&材料市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの生体吸収性医療用ポリマー&材料市場規模(種類別、用途別)
- 主要国別の生体吸収性医療用ポリマー&材料市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の生体吸収性医療用ポリマー&材料市場規模(種類別、用途別)
- 主要国別の生体吸収性医療用ポリマー&材料市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の生体吸収性医療用ポリマー&材料市場規模(種類別、用途別)
- 主要国別の生体吸収性医療用ポリマー&材料市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの生体吸収性医療用ポリマー&材料市場規模(種類別、用途別)
- 主要国別の生体吸収性医療用ポリマー&材料市場規模(トルコ、サウジアラビア)
・企業情報
Evonik、Corbion、DSM、Mitsui Chemicals、PCAS、Poly-Med、KLS Martin
・産業チェーン及び販売チャネル分析
- 生体吸収性医療用ポリマー&材料の産業チェーン分析
- 生体吸収性医療用ポリマー&材料の原材料
- 生体吸収性医療用ポリマー&材料の生産プロセス
- 生体吸収性医療用ポリマー&材料の販売及びマーケティング
- 生体吸収性医療用ポリマー&材料の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 生体吸収性医療用ポリマー&材料の産業動向
- 生体吸収性医療用ポリマー&材料のマーケットドライバー
- 生体吸収性医療用ポリマー&材料の課題
- 生体吸収性医療用ポリマー&材料の阻害要因
・主な調査結果

Applications for bioresorbable materials include bioresorbable stents and dissolvable sutures.
Market Analysis and Insights: Global Bioresorbable Medical Polymer and Material Market
Due to the COVID-19 pandemic, the global Bioresorbable Medical Polymer and Material market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, PLA accounting for % of the Bioresorbable Medical Polymer and Material global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Medical Devices segment is altered to an % CAGR throughout this forecast period.
China Bioresorbable Medical Polymer and Material market size is valued at US$ million in 2021, while the US and Europe Bioresorbable Medical Polymer and Material are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Bioresorbable Medical Polymer and Material landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Bioresorbable Medical Polymer and Material include Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, Poly-Med and KLS Martin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Bioresorbable Medical Polymer and Material capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Bioresorbable Medical Polymer and Material by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Bioresorbable Medical Polymer and Material Scope and Segment
Bioresorbable Medical Polymer and Material market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Bioresorbable Medical Polymer and Material market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
PLA
PGA
PCL
Polysaccharides
Others
Segment by Application
Medical Devices
Drug Delivery
Others
By Company
Evonik
Corbion
DSM
Mitsui Chemicals
PCAS
Poly-Med
KLS Martin
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Bioresorbable Medical Polymer and Material Product Introduction
1.2 Market by Type
1.2.1 Global Bioresorbable Medical Polymer and Material Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 PLA
1.2.3 PGA
1.2.4 PCL
1.2.5 Polysaccharides
1.2.6 Others
1.3 Market by Application
1.3.1 Global Bioresorbable Medical Polymer and Material Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Medical Devices
1.3.3 Drug Delivery
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Bioresorbable Medical Polymer and Material Production
2.1 Global Bioresorbable Medical Polymer and Material Production Capacity (2017-2028)
2.2 Global Bioresorbable Medical Polymer and Material Production by Region: 2017 VS 2021 VS 2028
2.3 Global Bioresorbable Medical Polymer and Material Production by Region
2.3.1 Global Bioresorbable Medical Polymer and Material Historic Production by Region (2017-2022)
2.3.2 Global Bioresorbable Medical Polymer and Material Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Bioresorbable Medical Polymer and Material Sales in Volume & Value Estimates and Forecasts
3.1 Global Bioresorbable Medical Polymer and Material Sales Estimates and Forecasts 2017-2028
3.2 Global Bioresorbable Medical Polymer and Material Revenue Estimates and Forecasts 2017-2028
3.3 Global Bioresorbable Medical Polymer and Material Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Bioresorbable Medical Polymer and Material Sales by Region
3.4.1 Global Bioresorbable Medical Polymer and Material Sales by Region (2017-2022)
3.4.2 Global Sales Bioresorbable Medical Polymer and Material by Region (2023-2028)
3.5 Global Bioresorbable Medical Polymer and Material Revenue by Region
3.5.1 Global Bioresorbable Medical Polymer and Material Revenue by Region (2017-2022)
3.5.2 Global Bioresorbable Medical Polymer and Material Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Bioresorbable Medical Polymer and Material Production Capacity by Manufacturers
4.2 Global Bioresorbable Medical Polymer and Material Sales by Manufacturers
4.2.1 Global Bioresorbable Medical Polymer and Material Sales by Manufacturers (2017-2022)
4.2.2 Global Bioresorbable Medical Polymer and Material Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Bioresorbable Medical Polymer and Material in 2021
4.3 Global Bioresorbable Medical Polymer and Material Revenue by Manufacturers
4.3.1 Global Bioresorbable Medical Polymer and Material Revenue by Manufacturers (2017-2022)
4.3.2 Global Bioresorbable Medical Polymer and Material Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Bioresorbable Medical Polymer and Material Revenue in 2021
4.4 Global Bioresorbable Medical Polymer and Material Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Bioresorbable Medical Polymer and Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Bioresorbable Medical Polymer and Material Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Bioresorbable Medical Polymer and Material Sales by Type
5.1.1 Global Bioresorbable Medical Polymer and Material Historical Sales by Type (2017-2022)
5.1.2 Global Bioresorbable Medical Polymer and Material Forecasted Sales by Type (2023-2028)
5.1.3 Global Bioresorbable Medical Polymer and Material Sales Market Share by Type (2017-2028)
5.2 Global Bioresorbable Medical Polymer and Material Revenue by Type
5.2.1 Global Bioresorbable Medical Polymer and Material Historical Revenue by Type (2017-2022)
5.2.2 Global Bioresorbable Medical Polymer and Material Forecasted Revenue by Type (2023-2028)
5.2.3 Global Bioresorbable Medical Polymer and Material Revenue Market Share by Type (2017-2028)
5.3 Global Bioresorbable Medical Polymer and Material Price by Type
5.3.1 Global Bioresorbable Medical Polymer and Material Price by Type (2017-2022)
5.3.2 Global Bioresorbable Medical Polymer and Material Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Bioresorbable Medical Polymer and Material Sales by Application
6.1.1 Global Bioresorbable Medical Polymer and Material Historical Sales by Application (2017-2022)
6.1.2 Global Bioresorbable Medical Polymer and Material Forecasted Sales by Application (2023-2028)
6.1.3 Global Bioresorbable Medical Polymer and Material Sales Market Share by Application (2017-2028)
6.2 Global Bioresorbable Medical Polymer and Material Revenue by Application
6.2.1 Global Bioresorbable Medical Polymer and Material Historical Revenue by Application (2017-2022)
6.2.2 Global Bioresorbable Medical Polymer and Material Forecasted Revenue by Application (2023-2028)
6.2.3 Global Bioresorbable Medical Polymer and Material Revenue Market Share by Application (2017-2028)
6.3 Global Bioresorbable Medical Polymer and Material Price by Application
6.3.1 Global Bioresorbable Medical Polymer and Material Price by Application (2017-2022)
6.3.2 Global Bioresorbable Medical Polymer and Material Price Forecast by Application (2023-2028)
7 North America
7.1 North America Bioresorbable Medical Polymer and Material Market Size by Type
7.1.1 North America Bioresorbable Medical Polymer and Material Sales by Type (2017-2028)
7.1.2 North America Bioresorbable Medical Polymer and Material Revenue by Type (2017-2028)
7.2 North America Bioresorbable Medical Polymer and Material Market Size by Application
7.2.1 North America Bioresorbable Medical Polymer and Material Sales by Application (2017-2028)
7.2.2 North America Bioresorbable Medical Polymer and Material Revenue by Application (2017-2028)
7.3 North America Bioresorbable Medical Polymer and Material Sales by Country
7.3.1 North America Bioresorbable Medical Polymer and Material Sales by Country (2017-2028)
7.3.2 North America Bioresorbable Medical Polymer and Material Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Bioresorbable Medical Polymer and Material Market Size by Type
8.1.1 Europe Bioresorbable Medical Polymer and Material Sales by Type (2017-2028)
8.1.2 Europe Bioresorbable Medical Polymer and Material Revenue by Type (2017-2028)
8.2 Europe Bioresorbable Medical Polymer and Material Market Size by Application
8.2.1 Europe Bioresorbable Medical Polymer and Material Sales by Application (2017-2028)
8.2.2 Europe Bioresorbable Medical Polymer and Material Revenue by Application (2017-2028)
8.3 Europe Bioresorbable Medical Polymer and Material Sales by Country
8.3.1 Europe Bioresorbable Medical Polymer and Material Sales by Country (2017-2028)
8.3.2 Europe Bioresorbable Medical Polymer and Material Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Bioresorbable Medical Polymer and Material Market Size by Type
9.1.1 Asia Pacific Bioresorbable Medical Polymer and Material Sales by Type (2017-2028)
9.1.2 Asia Pacific Bioresorbable Medical Polymer and Material Revenue by Type (2017-2028)
9.2 Asia Pacific Bioresorbable Medical Polymer and Material Market Size by Application
9.2.1 Asia Pacific Bioresorbable Medical Polymer and Material Sales by Application (2017-2028)
9.2.2 Asia Pacific Bioresorbable Medical Polymer and Material Revenue by Application (2017-2028)
9.3 Asia Pacific Bioresorbable Medical Polymer and Material Sales by Region
9.3.1 Asia Pacific Bioresorbable Medical Polymer and Material Sales by Region (2017-2028)
9.3.2 Asia Pacific Bioresorbable Medical Polymer and Material Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Bioresorbable Medical Polymer and Material Market Size by Type
10.1.1 Latin America Bioresorbable Medical Polymer and Material Sales by Type (2017-2028)
10.1.2 Latin America Bioresorbable Medical Polymer and Material Revenue by Type (2017-2028)
10.2 Latin America Bioresorbable Medical Polymer and Material Market Size by Application
10.2.1 Latin America Bioresorbable Medical Polymer and Material Sales by Application (2017-2028)
10.2.2 Latin America Bioresorbable Medical Polymer and Material Revenue by Application (2017-2028)
10.3 Latin America Bioresorbable Medical Polymer and Material Sales by Country
10.3.1 Latin America Bioresorbable Medical Polymer and Material Sales by Country (2017-2028)
10.3.2 Latin America Bioresorbable Medical Polymer and Material Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Bioresorbable Medical Polymer and Material Market Size by Type
11.1.1 Middle East and Africa Bioresorbable Medical Polymer and Material Sales by Type (2017-2028)
11.1.2 Middle East and Africa Bioresorbable Medical Polymer and Material Revenue by Type (2017-2028)
11.2 Middle East and Africa Bioresorbable Medical Polymer and Material Market Size by Application
11.2.1 Middle East and Africa Bioresorbable Medical Polymer and Material Sales by Application (2017-2028)
11.2.2 Middle East and Africa Bioresorbable Medical Polymer and Material Revenue by Application (2017-2028)
11.3 Middle East and Africa Bioresorbable Medical Polymer and Material Sales by Country
11.3.1 Middle East and Africa Bioresorbable Medical Polymer and Material Sales by Country (2017-2028)
11.3.2 Middle East and Africa Bioresorbable Medical Polymer and Material Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Evonik
12.1.1 Evonik Corporation Information
12.1.2 Evonik Overview
12.1.3 Evonik Bioresorbable Medical Polymer and Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Evonik Bioresorbable Medical Polymer and Material Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Evonik Recent Developments
12.2 Corbion
12.2.1 Corbion Corporation Information
12.2.2 Corbion Overview
12.2.3 Corbion Bioresorbable Medical Polymer and Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Corbion Bioresorbable Medical Polymer and Material Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Corbion Recent Developments
12.3 DSM
12.3.1 DSM Corporation Information
12.3.2 DSM Overview
12.3.3 DSM Bioresorbable Medical Polymer and Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 DSM Bioresorbable Medical Polymer and Material Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 DSM Recent Developments
12.4 Mitsui Chemicals
12.4.1 Mitsui Chemicals Corporation Information
12.4.2 Mitsui Chemicals Overview
12.4.3 Mitsui Chemicals Bioresorbable Medical Polymer and Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Mitsui Chemicals Bioresorbable Medical Polymer and Material Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Mitsui Chemicals Recent Developments
12.5 PCAS
12.5.1 PCAS Corporation Information
12.5.2 PCAS Overview
12.5.3 PCAS Bioresorbable Medical Polymer and Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 PCAS Bioresorbable Medical Polymer and Material Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 PCAS Recent Developments
12.6 Poly-Med
12.6.1 Poly-Med Corporation Information
12.6.2 Poly-Med Overview
12.6.3 Poly-Med Bioresorbable Medical Polymer and Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Poly-Med Bioresorbable Medical Polymer and Material Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Poly-Med Recent Developments
12.7 KLS Martin
12.7.1 KLS Martin Corporation Information
12.7.2 KLS Martin Overview
12.7.3 KLS Martin Bioresorbable Medical Polymer and Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 KLS Martin Bioresorbable Medical Polymer and Material Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 KLS Martin Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Bioresorbable Medical Polymer and Material Industry Chain Analysis
13.2 Bioresorbable Medical Polymer and Material Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Bioresorbable Medical Polymer and Material Production Mode & Process
13.4 Bioresorbable Medical Polymer and Material Sales and Marketing
13.4.1 Bioresorbable Medical Polymer and Material Sales Channels
13.4.2 Bioresorbable Medical Polymer and Material Distributors
13.5 Bioresorbable Medical Polymer and Material Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Bioresorbable Medical Polymer and Material Industry Trends
14.2 Bioresorbable Medical Polymer and Material Market Drivers
14.3 Bioresorbable Medical Polymer and Material Market Challenges
14.4 Bioresorbable Medical Polymer and Material Market Restraints
15 Key Finding in The Global Bioresorbable Medical Polymer and Material Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の生体吸収性医療用ポリマー&材料市場インサイト及び予測(PLA、PGA、PCL、多糖類、その他)(Global Bioresorbable Medical Polymer and Material Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。